BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Gross Profit 2022–2025
BioXcel Therapeutics, Inc. annual/quarterly gross profit history and growth rate from 2022 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- BioXcel Therapeutics, Inc. gross profit for the quarter ending March 31, 2026 was -77000, a 150.00% decrease year-over-year.
- BioXcel Therapeutics, Inc. gross profit for the twelve months ending March 31, 2026 was 177000, a 57.55% decrease year-over-year.
- BioXcel Therapeutics, Inc. annual gross profit for 2025 was 478000, a 288.62% increase from 2024.
- BioXcel Therapeutics, Inc. annual gross profit for 2024 was 123000, a 2.50% increase from 2023.
- BioXcel Therapeutics, Inc. annual gross profit for 2023 was 120000, a 66.20% decrease from 2022.
- BioXcel Therapeutics, Inc. annual gross profit for 2022 was 355000.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioXcel Therapeutics, Inc. Gross Profit — FAQ
BioXcel Therapeutics, Inc. (BTAI) gross profit over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is BioXcel Therapeutics, Inc.'s gross profit?
BioXcel Therapeutics, Inc. (BTAI) reported gross profit of $478,000 for fiscal 2025.
Where can I see BTAI's gross profit history?
The chart and table above show BioXcel Therapeutics, Inc.'s gross profit by year and by quarter, including the growth rate.